OBJECTIVESTo investigate the subjective treatment goals of insulin-treated diabetic patients.METHODS297 type 1 and 205 type 2 diabetic patients, representative of the North-western Swiss population, filled out a self report questionnaire focusing on their own treatment goals using standardized measures wherever available. Factor analysis of the 16 items reflecting their treatment goals revealed four subscales (Crohnbach's alpha): High actual quality of life (0.73), weight reduction/maintenance and daily hassles (0.68), good medical care and knowledge (0.64) and good long term glucose control (0.71).RESULTSGood long term glucose control was the single most important main treatment goal for most patients (type 1: 60.2%, type 2: 49.7%, p = 0.0...
OBJECTIVE Observations over the past few years have demonstrated the need to adjust glycemic targets...
Objective: To investigate perceptions of control among people with uncontrolled and well controlled ...
Background: Few studies evaluate patients' perspectives when a new drug is introduced to treat chron...
OBJECTIVESTo investigate the subjective treatment goals of insulin-treated diabetic patients.METHODS...
OBJECTIVES: To investigate the subjective treatment goals of insulin-treated diabetic patients. METH...
To investigate the subjective treatment goals of insulin-treated diabetic patients. 297 type 1 and 2...
BACKGROUNDDespite increasing importance of patient self-management, little is known about their own ...
AbstractAimsTo investigate treatment patterns and achievement of glycemic targets in patients with t...
OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their dia...
OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their dia...
We performed a survey of 305 patients with type 2 diabetes receiving basal insulin and 240 physician...
Although physicians commonly report that they use goals in intro-ducing diabetic regimens, little is...
The current guidelines for improving the care of people with type 2 diabetes (diabetes mellitus) sug...
Worldwide, there are 415 million people living with diabetes. Many of them need insulin therapy to a...
Fernando J Lavalle-González,1 Erwin Chiquete2 On behalf of the IDMPS-3W Collaborative Group ...
OBJECTIVE Observations over the past few years have demonstrated the need to adjust glycemic targets...
Objective: To investigate perceptions of control among people with uncontrolled and well controlled ...
Background: Few studies evaluate patients' perspectives when a new drug is introduced to treat chron...
OBJECTIVESTo investigate the subjective treatment goals of insulin-treated diabetic patients.METHODS...
OBJECTIVES: To investigate the subjective treatment goals of insulin-treated diabetic patients. METH...
To investigate the subjective treatment goals of insulin-treated diabetic patients. 297 type 1 and 2...
BACKGROUNDDespite increasing importance of patient self-management, little is known about their own ...
AbstractAimsTo investigate treatment patterns and achievement of glycemic targets in patients with t...
OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their dia...
OBJECTIVE: Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their dia...
We performed a survey of 305 patients with type 2 diabetes receiving basal insulin and 240 physician...
Although physicians commonly report that they use goals in intro-ducing diabetic regimens, little is...
The current guidelines for improving the care of people with type 2 diabetes (diabetes mellitus) sug...
Worldwide, there are 415 million people living with diabetes. Many of them need insulin therapy to a...
Fernando J Lavalle-González,1 Erwin Chiquete2 On behalf of the IDMPS-3W Collaborative Group ...
OBJECTIVE Observations over the past few years have demonstrated the need to adjust glycemic targets...
Objective: To investigate perceptions of control among people with uncontrolled and well controlled ...
Background: Few studies evaluate patients' perspectives when a new drug is introduced to treat chron...